| Owner |
Relationship |
Date |
Transaction |
Cost |
# Shares |
Value($) |
Total Shares |
Form |
Form 4 |
| ZIEGLER JOHN B |
Director |
May 22 |
Option Exercise |
$44.70 |
31,362 |
1,401,767 |
49,191 |
4 |
May 23, 06:47 PM |
| ZIEGLER JOHN B |
Director |
May 22 |
Sale |
$62.00 |
31,362 |
1,944,444 |
17,829 |
4 |
May 23, 06:47 PM |
| Doherty Catherine T. |
SVP, Clinical Franchises |
May 16 |
Option Exercise |
$59.90 |
276 |
16,534 |
72,079 |
4 |
May 17, 04:32 PM |
| BALDWIN JOHN C MD |
Director |
May 14 |
Sale |
$59.41 |
1,214 |
72,122 |
8,634 |
4 |
May 15, 04:39 PM |
| WILENSKY GAIL R |
Director |
May 02 |
Option Exercise |
$55.40 |
10,000 |
554,000 |
23,952 |
4 |
May 03, 04:33 PM |
| WILENSKY GAIL R |
Director |
May 02 |
Sale |
$57.20 |
10,000 |
572,008 |
13,952 |
4 |
May 03, 04:33 PM |
| RUSCKOWSKI STEPHEN H |
President and CEO |
May 01 |
Option Exercise |
$56.69 |
2,721 |
154,253 |
91,580 |
4 |
May 03, 04:32 PM |
| ORDONEZ KATHY |
SVP, Diagnostic Solutions |
Mar 31 |
Option Exercise |
$56.22 |
245 |
13,775 |
9,569 |
4 |
Apr 02, 04:38 PM |
| RUSCKOWSKI STEPHEN H |
President and CEO |
Mar 05 |
Option Exercise |
$56.35 |
1,588 |
89,476 |
98,591 |
4 |
Mar 07, 04:33 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Mar 05 |
Option Exercise |
$56.35 |
1,183 |
66,656 |
47,120 |
4 |
Mar 07, 04:32 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Mar 06 |
Sale |
$56.46 |
1,992 |
112,465 |
47,100 |
4 |
Mar 07, 04:32 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Mar 05 |
Option Exercise |
$56.35 |
3,084 |
173,768 |
126,722 |
4 |
Mar 07, 04:30 PM |
| Cohen Jon R |
SVP and Chief Medical Officer |
Mar 05 |
Option Exercise |
$56.35 |
2,001 |
112,746 |
54,232 |
4 |
Mar 07, 04:28 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Mar 05 |
Option Exercise |
$56.35 |
395 |
22,256 |
12,770 |
4 |
Mar 07, 04:26 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Mar 04 |
Option Exercise |
$55.97 |
1,182 |
66,157 |
123,281 |
4 |
Mar 06, 04:40 PM |
| Doherty Catherine T. |
SVP, Clinical Franchises |
Mar 04 |
Option Exercise |
$55.97 |
661 |
36,996 |
70,575 |
4 |
Mar 06, 04:39 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Mar 04 |
Option Exercise |
$55.97 |
171 |
9,571 |
12,106 |
4 |
Mar 06, 04:38 PM |
| Cohen Jon R |
SVP and Chief Medical Officer |
Mar 04 |
Option Exercise |
$55.97 |
617 |
34,533 |
52,000 |
4 |
Mar 06, 04:36 PM |
| ZIEGLER JOHN B |
Director |
Feb 20 |
Sale |
$57.42 |
2,000 |
114,840 |
15,854 |
4 |
Feb 22, 04:33 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Feb 15 |
Option Exercise |
$56.97 |
857 |
48,823 |
42,529 |
4 |
Feb 19, 04:50 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Feb 19 |
Sale |
$57.53 |
1,442 |
82,961 |
41,087 |
4 |
Feb 19, 04:50 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Feb 15 |
Option Exercise |
$56.97 |
1,761 |
100,324 |
115,133 |
4 |
Feb 19, 04:48 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Feb 15 |
Option Exercise |
$56.97 |
279 |
15,895 |
10,298 |
4 |
Feb 19, 04:44 PM |
| Doherty Catherine T. |
SVP, Clinical Franchises |
Feb 15 |
Option Exercise |
$56.97 |
712 |
40,563 |
64,133 |
4 |
Feb 19, 04:41 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Feb 10 |
Option Exercise |
$58.45 |
1,358 |
79,375 |
46,867 |
4 |
Feb 12, 05:00 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Feb 12 |
Sale |
$57.48 |
3,481 |
200,074 |
43,386 |
4 |
Feb 12, 05:00 PM |
| Doherty Catherine T. |
SVP, Clinical Franchises |
Feb 10 |
Option Exercise |
$58.45 |
1,453 |
84,928 |
64,845 |
4 |
Feb 12, 04:55 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Feb 10 |
Option Exercise |
$58.45 |
3,726 |
217,785 |
116,894 |
4 |
Feb 12, 04:37 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Feb 10 |
Option Exercise |
$58.45 |
662 |
38,694 |
10,577 |
4 |
Feb 12, 04:34 PM |
| PFEIFFER GARY M |
Director |
Jan 17 |
Option Exercise |
$55.40 |
10,000 |
554,000 |
23,952 |
4 |
Jan 18, 04:30 PM |
| PFEIFFER GARY M |
Director |
Jan 17 |
Sale |
$60.00 |
10,000 |
600,000 |
13,952 |
4 |
Jan 18, 04:30 PM |
| ORDONEZ KATHY |
SVP, Discovery & Development |
Dec 31 |
Option Exercise |
$58.24 |
239 |
13,921 |
10,166 |
4 |
Jan 02, 04:26 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Oct 03 |
Option Exercise |
$40.43 |
46,667 |
1,886,630 |
201,233 |
4 |
Oct 05, 04:24 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Oct 03 |
Sale |
$64.00 |
46,667 |
2,986,688 |
154,603 |
4 |
Oct 05, 04:24 PM |
| ORDONEZ KATHY |
SVP, Discovery & Development |
Sep 30 |
Option Exercise |
$63.19 |
239 |
15,101 |
10,400 |
4 |
Oct 02, 04:34 PM |
| ZIEGLER JOHN B |
Director |
Sep 06 |
Option Exercise |
$55.40 |
10,000 |
554,000 |
27,854 |
4 |
Sep 07, 04:30 PM |
| ZIEGLER JOHN B |
Director |
Sep 06 |
Sale |
$62.32 |
10,000 |
623,192 |
17,854 |
4 |
Sep 07, 04:30 PM |
| WILENSKY GAIL R |
Director |
Aug 15 |
Option Exercise |
$30.45 |
20,000 |
609,100 |
33,952 |
4 |
Aug 16, 04:18 PM |
| WILENSKY GAIL R |
Director |
Aug 15 |
Sale |
$59.24 |
20,000 |
1,184,718 |
13,952 |
4 |
Aug 16, 04:18 PM |
| BUEHLER WILLIAM F |
Director |
Aug 10 |
Option Exercise |
$38.77 |
30,000 |
1,163,100 |
44,250 |
4 |
Aug 14, 04:12 PM |
| BUEHLER WILLIAM F |
Director |
Aug 10 |
Sale |
$59.31 |
30,000 |
1,779,164 |
24,250 |
4 |
Aug 14, 04:12 PM |
| Doherty Catherine T. |
SVP, Physician Services |
Aug 08 |
Option Exercise |
$52.24 |
40,000 |
2,089,400 |
105,914 |
4 |
Aug 09, 04:20 PM |
| Doherty Catherine T. |
SVP, Physician Services |
Aug 08 |
Sale |
$60.11 |
40,000 |
2,404,324 |
66,016 |
4 |
Aug 09, 04:20 PM |
| BALDWIN JOHN C MD |
Director |
Aug 08 |
Option Exercise |
$55.40 |
10,000 |
554,000 |
21,618 |
4 |
Aug 09, 04:18 PM |
| BALDWIN JOHN C MD |
Director |
Aug 08 |
Sale |
$60.00 |
11,770 |
706,165 |
11,618 |
4 |
Aug 09, 04:18 PM |
| ZIEGLER JOHN B |
Director |
Aug 03 |
Sale |
$59.26 |
2,800 |
165,916 |
17,854 |
4 |
Aug 06, 04:09 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Aug 01 |
Option Exercise |
$42.13 |
86,445 |
3,642,354 |
134,474 |
4 |
Aug 02, 04:07 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Jul 31 |
Option Exercise |
$24.76 |
40,222 |
995,897 |
65,435 |
4 |
Aug 02, 04:07 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Jul 31 |
Sale |
$58.59 |
28,814 |
1,688,270 |
36,621 |
4 |
Aug 02, 04:07 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Aug 01 |
Sale |
$58.68 |
86,445 |
5,072,299 |
48,111 |
4 |
Aug 02, 04:07 PM |
| STANZIONE DANIEL |
Director |
Jul 12 |
Option Exercise |
$38.77 |
30,000 |
1,163,100 |
50,176 |
4 |
Jul 13, 04:13 PM |
| STANZIONE DANIEL |
Director |
Jul 12 |
Sale |
$62.00 |
30,000 |
1,860,000 |
20,176 |
4 |
Jul 13, 04:13 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Jun 29 |
Option Exercise |
$52.24 |
15,000 |
783,525 |
25,941 |
4 |
Jul 03, 01:31 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Jun 29 |
Sale |
$59.54 |
15,000 |
893,100 |
10,973 |
4 |
Jul 03, 01:31 PM |
| ZIEGLER JOHN B |
Director |
Jun 28 |
Option Exercise |
$30.45 |
20,000 |
609,100 |
40,654 |
4 |
Jul 02, 05:22 PM |
| ZIEGLER JOHN B |
Director |
Jun 28 |
Sale |
$59.00 |
20,000 |
1,180,000 |
20,654 |
4 |
Jul 02, 05:22 PM |
| ZIEGLER JOHN B |
Director |
May 30 |
Option Exercise |
$29.46 |
864 |
25,452 |
21,518 |
4 |
May 31, 04:40 PM |
| ZIEGLER JOHN B |
Director |
May 30 |
Sale |
$58.13 |
864 |
50,224 |
20,654 |
4 |
May 31, 04:40 PM |
| Doherty Catherine T. |
SVP, Physician Services |
May 16 |
Option Exercise |
$57.18 |
343 |
19,613 |
65,914 |
4 |
May 18, 03:00 PM |
| Cohen Jon R |
SVP, Hosp. Services and CMO |
May 13 |
Option Exercise |
$57.65 |
2,991 |
172,446 |
47,972 |
4 |
May 15, 04:18 PM |
| RUSCKOWSKI STEPHEN H |
President and CEO |
May 08 |
Buy |
$56.89 |
20,000 |
1,137,748 |
63,034 |
4 |
May 09, 04:40 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
May 08 |
Sale |
$56.83 |
1 |
57 |
0 |
4 |
May 09, 04:39 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
May 01 |
Sale |
$58.43 |
2,305 |
134,686 |
1 |
4 |
May 03, 05:53 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
May 01 |
Option Exercise |
$57.50 |
7,610 |
437,575 |
10,941 |
4 |
May 03, 04:35 PM |
| PFEIFFER GARY M |
Director |
May 02 |
Option Exercise |
$53.27 |
10,000 |
532,675 |
21,977 |
4 |
May 03, 04:34 PM |
| PFEIFFER GARY M |
Director |
May 02 |
Sale |
$58.30 |
10,000 |
583,041 |
11,977 |
4 |
May 03, 04:34 PM |
| BALDWIN JOHN C MD |
Director |
May 01 |
Option Exercise |
$49.94 |
8,000 |
399,520 |
19,977 |
4 |
May 03, 04:33 PM |
| BALDWIN JOHN C MD |
Director |
May 01 |
Sale |
$57.50 |
10,334 |
594,205 |
9,643 |
4 |
May 03, 04:33 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Apr 30 |
Option Exercise |
$57.51 |
26,893 |
1,546,616 |
243,713 |
4 |
May 02, 04:24 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Apr 02 |
Option Exercise |
$40.43 |
46,666 |
1,886,590 |
201,232 |
4 |
Apr 03, 04:20 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Apr 02 |
Sale |
$62.00 |
46,666 |
2,893,292 |
154,566 |
4 |
Apr 03, 04:20 PM |
| ORDONEZ KATHY |
SVP, Discovery & Development |
Apr 02 |
Option Exercise |
$61.04 |
239 |
14,589 |
10,870 |
4 |
Apr 03, 04:19 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Feb 29 |
Option Exercise |
$58.24 |
4,117 |
239,774 |
43,828 |
4 |
Mar 02, 04:50 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Mar 01 |
Sale |
$57.40 |
7,207 |
413,656 |
36,621 |
4 |
Mar 02, 04:50 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Feb 29 |
Option Exercise |
$58.24 |
25,950 |
1,511,328 |
270,289 |
4 |
Mar 02, 04:49 PM |
| Miller Joan Elizabeth |
SVP-Oncology & Neurology Srvcs |
Feb 29 |
Option Exercise |
$58.24 |
5,077 |
295,684 |
89,232 |
4 |
Mar 02, 04:48 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Feb 29 |
Option Exercise |
$58.24 |
10,788 |
628,293 |
154,566 |
4 |
Mar 02, 04:47 PM |
| Doherty Catherine T. |
SVP, Physician Services |
Feb 29 |
Option Exercise |
$58.24 |
3,248 |
189,164 |
66,156 |
4 |
Mar 02, 04:45 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Feb 29 |
Option Exercise |
$58.24 |
1,373 |
79,964 |
18,411 |
4 |
Mar 02, 04:44 PM |
| Cohen Jon R |
SVP, Hosp. Services and CMO |
Feb 29 |
Option Exercise |
$58.24 |
5,489 |
319,679 |
50,625 |
4 |
Mar 02, 04:41 PM |
| Miller Joan Elizabeth |
SVP-Oncology & Neurology Srvcs |
Feb 24 |
Option Exercise |
$56.60 |
15,561 |
880,789 |
88,934 |
4 |
Feb 27, 04:14 PM |
| Miller Joan Elizabeth |
SVP-Oncology & Neurology Srvcs |
Feb 24 |
Sale |
$57.45 |
15,561 |
893,979 |
73,373 |
4 |
Feb 27, 04:14 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Feb 21 |
Option Exercise |
$56.87 |
7,078 |
402,557 |
21,248 |
4 |
Feb 22, 04:15 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Feb 21 |
Sale |
$57.50 |
7,078 |
406,985 |
14,170 |
4 |
Feb 22, 04:15 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Feb 16 |
Option Exercise |
$57.08 |
5,268 |
300,671 |
240,254 |
4 |
Feb 17, 04:42 PM |
| Miller Joan Elizabeth |
SVP-Oncology & Neurology Srvcs |
Feb 15 |
Option Exercise |
$56.80 |
1,124 |
63,843 |
73,373 |
4 |
Feb 16, 04:23 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Feb 15 |
Option Exercise |
$56.80 |
2,190 |
124,392 |
132,079 |
4 |
Feb 16, 04:22 PM |
| Doherty Catherine T. |
SVP, Physician Services Bus. |
Feb 15 |
Option Exercise |
$56.80 |
694 |
39,419 |
53,374 |
4 |
Feb 16, 04:21 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Feb 15 |
Option Exercise |
$56.80 |
279 |
15,847 |
14,170 |
4 |
Feb 16, 04:20 PM |
| Cohen Jon R |
SVP, Hosp. Svcs. Bus. and CMO |
Feb 15 |
Option Exercise |
$56.80 |
1,114 |
63,275 |
34,396 |
4 |
Feb 16, 04:19 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Feb 15 |
Option Exercise |
$56.80 |
836 |
47,485 |
33,118 |
4 |
Feb 16, 04:18 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Feb 14 |
Sale |
$57.40 |
4,544 |
260,822 |
36,996 |
4 |
Feb 16, 04:18 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Feb 13 |
Option Exercise |
$57.12 |
1,797 |
102,636 |
38,498 |
4 |
Feb 14, 12:25 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Feb 10 |
Option Exercise |
$57.12 |
918 |
52,432 |
40,140 |
4 |
Feb 14, 12:25 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Feb 10 |
Option Exercise |
$57.12 |
5,545 |
316,703 |
194,581 |
4 |
Feb 14, 12:24 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Feb 13 |
Option Exercise |
$57.12 |
11,090 |
633,405 |
183,491 |
4 |
Feb 14, 12:24 PM |
| Miller Joan Elizabeth |
SVP-Oncology & Neurology Srvcs |
Feb 13 |
Option Exercise |
$57.12 |
2,177 |
124,339 |
74,497 |
4 |
Feb 14, 12:23 PM |
| Miller Joan Elizabeth |
SVP-Oncology & Neurology Srvcs |
Feb 10 |
Option Exercise |
$57.12 |
1,191 |
68,024 |
76,674 |
4 |
Feb 14, 12:23 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Feb 10 |
Option Exercise |
$57.12 |
1,808 |
103,264 |
137,867 |
4 |
Feb 14, 12:21 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Feb 13 |
Option Exercise |
$57.12 |
3,616 |
206,528 |
134,269 |
4 |
Feb 14, 12:21 PM |
| Doherty Catherine T. |
SVP, Physician Services Bus. |
Feb 13 |
Option Exercise |
$57.12 |
1,428 |
81,560 |
54,068 |
4 |
Feb 14, 12:20 PM |
| Doherty Catherine T. |
SVP, Physician Services Bus. |
Feb 10 |
Option Exercise |
$57.12 |
734 |
41,922 |
55,323 |
4 |
Feb 14, 12:20 PM |
| Cohen Jon R |
SVP, Hosp. Svcs. Bus. and CMO |
Feb 10 |
Option Exercise |
$57.12 |
1,202 |
68,652 |
35,510 |
4 |
Feb 14, 12:20 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Feb 13 |
Option Exercise |
$57.12 |
638 |
36,439 |
14,449 |
4 |
Feb 14, 12:19 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Feb 10 |
Option Exercise |
$57.12 |
328 |
18,734 |
14,931 |
4 |
Feb 14, 12:19 PM |
| Miller Joan Elizabeth |
SVP-Oncology & Neurology Srvcs |
Feb 03 |
Option Exercise |
$55.65 |
13,333 |
741,981 |
91,072 |
4 |
Feb 07, 04:05 PM |
| Miller Joan Elizabeth |
SVP-Oncology & Neurology Srvcs |
Feb 03 |
Sale |
$58.50 |
13,333 |
779,981 |
77,865 |
4 |
Feb 07, 04:05 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Feb 01 |
Option Exercise |
$48.74 |
20,556 |
1,001,899 |
220,682 |
4 |
Feb 01, 04:16 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Feb 01 |
Sale |
$58.38 |
20,556 |
1,200,026 |
200,126 |
4 |
Feb 01, 04:16 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Jan 30 |
Sale |
$58.17 |
90,000 |
5,235,516 |
200,126 |
4 |
Feb 01, 04:16 PM |
| WILENSKY GAIL R |
Director |
Jan 27 |
Option Exercise |
$49.40 |
30,000 |
1,481,975 |
31,977 |
4 |
Jan 30, 04:44 PM |
| WILENSKY GAIL R |
Director |
Jan 27 |
Sale |
$58.93 |
30,000 |
1,767,868 |
11,977 |
4 |
Jan 30, 04:44 PM |
| STANZIONE DANIEL |
Director |
Jan 27 |
Option Exercise |
$49.40 |
30,000 |
1,481,975 |
38,201 |
4 |
Jan 30, 04:42 PM |
| STANZIONE DANIEL |
Director |
Jan 27 |
Sale |
$59.00 |
30,000 |
1,770,006 |
18,201 |
4 |
Jan 30, 04:42 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Jan 26 |
Option Exercise |
$52.24 |
113,334 |
5,920,002 |
253,009 |
4 |
Jan 30, 04:41 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Jan 26 |
Sale |
$59.15 |
113,334 |
6,704,271 |
152,405 |
4 |
Jan 30, 04:41 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Jan 26 |
Option Exercise |
$40.43 |
220,268 |
8,904,885 |
510,095 |
4 |
Jan 30, 04:40 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Jan 27 |
Option Exercise |
$40.43 |
119,732 |
4,840,466 |
409,559 |
4 |
Jan 30, 04:40 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Jan 27 |
Sale |
$59.04 |
119,732 |
7,069,013 |
290,126 |
4 |
Jan 30, 04:40 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Jan 26 |
Sale |
$59.12 |
220,268 |
13,022,420 |
289,827 |
4 |
Jan 30, 04:40 PM |
| BALDWIN JOHN C MD |
Director |
Jan 26 |
Option Exercise |
$53.27 |
10,000 |
532,675 |
21,977 |
4 |
Jan 30, 04:39 PM |
| BALDWIN JOHN C MD |
Director |
Jan 26 |
Sale |
$59.00 |
10,000 |
590,005 |
11,977 |
4 |
Jan 30, 04:39 PM |
| BUEHLER WILLIAM F |
Director |
Jan 26 |
Option Exercise |
$49.40 |
30,000 |
1,481,975 |
52,275 |
4 |
Jan 30, 04:37 PM |
| BUEHLER WILLIAM F |
Director |
Jan 26 |
Sale |
$58.83 |
30,000 |
1,764,774 |
22,275 |
4 |
Jan 30, 04:37 PM |
| ORDONEZ KATHY |
SVP, Discovery & Development |
Dec 31 |
Option Exercise |
$58.16 |
266 |
15,471 |
7,235 |
4 |
Jan 03, 04:07 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Dec 21 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
142,175 |
4 |
Dec 22, 04:18 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Dec 21 |
Sale |
$57.75 |
4,150 |
239,671 |
139,675 |
4 |
Dec 22, 04:18 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Dec 01 |
Option Exercise |
$48.74 |
20,556 |
1,001,899 |
310,383 |
4 |
Dec 02, 04:23 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Dec 01 |
Sale |
$57.95 |
20,556 |
1,191,187 |
289,827 |
4 |
Dec 02, 04:23 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Dec 01 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
142,175 |
4 |
Dec 02, 04:22 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Dec 01 |
Sale |
$58.15 |
4,150 |
241,317 |
139,675 |
4 |
Dec 02, 04:22 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Nov 21 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
142,175 |
4 |
Nov 22, 04:14 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Nov 21 |
Sale |
$54.40 |
4,150 |
225,760 |
139,675 |
4 |
Nov 22, 04:14 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Nov 08 |
Option Exercise |
$48.74 |
13,334 |
649,899 |
28,468 |
4 |
Nov 10, 04:18 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Nov 08 |
Sale |
$57.50 |
13,334 |
766,705 |
15,259 |
4 |
Nov 10, 04:18 PM |
| BRITELL JENNE K |
Director |
Nov 03 |
Option Exercise |
$47.45 |
7,500 |
355,875 |
19,977 |
4 |
Nov 03, 04:20 PM |
| BRITELL JENNE K |
Director |
Nov 03 |
Sale |
$55.70 |
7,500 |
417,750 |
12,477 |
4 |
Nov 03, 04:20 PM |
| ZIEGLER JOHN B |
Director |
Oct 28 |
Option Exercise |
$52.98 |
12,997 |
688,607 |
31,676 |
4 |
Nov 01, 04:26 PM |
| ZIEGLER JOHN B |
Director |
Oct 28 |
Sale |
$57.28 |
12,997 |
744,501 |
18,679 |
4 |
Nov 01, 04:26 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Oct 28 |
Option Exercise |
$24.76 |
50,000 |
1,238,000 |
339,827 |
4 |
Nov 01, 04:24 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Oct 28 |
Sale |
$57.41 |
50,000 |
2,870,500 |
289,827 |
4 |
Nov 01, 04:24 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Oct 27 |
Option Exercise |
$41.00 |
116,000 |
4,755,730 |
109,058 |
4 |
Oct 31, 03:39 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Oct 27 |
Sale |
$56.68 |
116,000 |
6,574,892 |
41,058 |
4 |
Oct 31, 03:39 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Oct 25 |
Option Exercise |
$48.74 |
48,047 |
2,341,811 |
337,688 |
4 |
Oct 27, 04:09 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Oct 25 |
Sale |
$56.49 |
48,047 |
2,714,175 |
289,827 |
4 |
Oct 27, 04:09 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Oct 21 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
143,813 |
4 |
Oct 25, 04:13 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Oct 21 |
Sale |
$49.29 |
4,150 |
204,554 |
139,663 |
4 |
Oct 25, 04:13 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Oct 03 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
142,163 |
4 |
Oct 05, 04:23 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Oct 03 |
Sale |
$49.23 |
4,150 |
204,315 |
139,663 |
4 |
Oct 05, 04:23 PM |
| ORDONEZ KATHY |
SVP, Discovery & Development |
Sep 30 |
Option Exercise |
$50.10 |
304 |
15,230 |
7,500 |
4 |
Oct 04, 04:20 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Sep 21 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
142,163 |
4 |
Sep 23, 04:14 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Sep 21 |
Sale |
$49.51 |
4,150 |
205,467 |
139,663 |
4 |
Sep 23, 04:14 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Sep 01 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
142,163 |
4 |
Sep 06, 04:29 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Sep 01 |
Sale |
$49.98 |
4,150 |
207,410 |
139,663 |
4 |
Sep 06, 04:29 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Aug 29 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
143,813 |
4 |
Aug 31, 04:18 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Aug 29 |
Sale |
$49.00 |
4,150 |
203,350 |
139,663 |
4 |
Aug 31, 04:18 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Aug 17 |
Sale |
$49.29 |
1,500 |
73,939 |
15,134 |
4 |
Aug 18, 04:37 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Aug 01 |
Option Exercise |
$48.74 |
13,620 |
663,839 |
370,692 |
4 |
Aug 03, 04:09 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Aug 01 |
Sale |
$54.12 |
13,620 |
737,093 |
357,262 |
4 |
Aug 03, 04:09 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Aug 01 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
142,152 |
4 |
Aug 03, 04:07 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Aug 01 |
Sale |
$54.27 |
4,150 |
225,218 |
139,663 |
4 |
Aug 03, 04:07 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Jul 21 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
142,152 |
4 |
Jul 25, 11:52 AM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Jul 21 |
Sale |
$57.18 |
4,150 |
237,304 |
139,652 |
4 |
Jul 25, 11:52 AM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Jul 01 |
Option Exercise |
$48.74 |
20,555 |
1,001,851 |
377,627 |
4 |
Jul 05, 04:45 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Jul 01 |
Sale |
$58.96 |
20,555 |
1,211,954 |
357,072 |
4 |
Jul 05, 04:45 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Jul 01 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
142,152 |
4 |
Jul 05, 04:41 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Jul 01 |
Sale |
$58.98 |
4,150 |
244,749 |
139,652 |
4 |
Jul 05, 04:41 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Jun 21 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
142,152 |
4 |
Jun 22, 11:45 AM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Jun 21 |
Sale |
$60.68 |
4,150 |
251,811 |
139,652 |
4 |
Jun 22, 11:45 AM |
| Simmons Wayne R. |
Vice President, Operations |
Jun 16 |
Option Exercise |
$48.74 |
16,000 |
779,840 |
63,109 |
4 |
Jun 20, 04:31 PM |
| Simmons Wayne R. |
Vice President, Operations |
Jun 16 |
Sale |
$60.00 |
16,000 |
960,000 |
47,150 |
4 |
Jun 20, 04:31 PM |
| Miller Joan Elizabeth |
SVP-Oncology & Neurology Srvcs |
Jun 16 |
Sale |
$60.20 |
3,815 |
229,663 |
77,583 |
4 |
Jun 20, 04:28 PM |
| Miller Joan Elizabeth |
SVP-Oncology & Neurology Srvcs |
Jun 14 |
Sale |
$59.70 |
4,668 |
278,680 |
81,398 |
4 |
Jun 16, 04:38 PM |
| Miller Joan Elizabeth |
SVP-Oncology & Neurology Srvcs |
Jun 13 |
Sale |
$59.20 |
10,615 |
628,408 |
86,066 |
4 |
Jun 14, 04:29 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Jun 01 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
143,802 |
4 |
Jun 03, 04:06 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Jun 01 |
Sale |
$58.10 |
4,150 |
241,103 |
141,302 |
4 |
Jun 03, 04:06 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Jun 01 |
Option Exercise |
$48.74 |
20,555 |
1,001,851 |
377,627 |
4 |
Jun 02, 04:23 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Jun 01 |
Sale |
$58.06 |
20,555 |
1,193,512 |
357,072 |
4 |
Jun 02, 04:23 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
May 23 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
142,152 |
4 |
May 25, 04:18 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
May 23 |
Sale |
$57.46 |
4,150 |
238,456 |
139,652 |
4 |
May 25, 04:18 PM |
| Miller Joan Elizabeth |
SVP-Oncology & Neurology Srvcs |
May 18 |
Option Exercise |
$47.49 |
21,112 |
1,002,609 |
117,773 |
4 |
May 19, 04:33 PM |
| Miller Joan Elizabeth |
SVP-Oncology & Neurology Srvcs |
May 17 |
Sale |
$57.93 |
1,809 |
104,795 |
1,039 |
4 |
May 19, 04:33 PM |
| Miller Joan Elizabeth |
SVP-Oncology & Neurology Srvcs |
May 18 |
Sale |
$58.10 |
21,112 |
1,226,506 |
106,661 |
4 |
May 19, 04:33 PM |
| Simmons Wayne R. |
Vice President, Operations |
May 11 |
Sale |
$57.00 |
10,000 |
570,000 |
47,109 |
4 |
May 13, 04:06 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
May 02 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
142,141 |
4 |
May 04, 04:17 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
May 02 |
Sale |
$56.46 |
4,150 |
234,314 |
139,652 |
4 |
May 04, 04:17 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Apr 21 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
142,141 |
4 |
Apr 25, 04:11 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Apr 21 |
Sale |
$58.28 |
4,150 |
241,870 |
139,641 |
4 |
Apr 25, 04:11 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Mar 21 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
142,141 |
4 |
Mar 23, 04:19 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Mar 21 |
Sale |
$54.20 |
4,150 |
224,910 |
139,641 |
4 |
Mar 23, 04:19 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Mar 09 |
Sale |
$57.50 |
2,596 |
149,266 |
41,058 |
4 |
Mar 11, 04:29 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Mar 04 |
Option Exercise |
$56.51 |
4,611 |
260,545 |
139,641 |
4 |
Mar 08, 04:33 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Mar 04 |
Option Exercise |
$56.51 |
11,090 |
626,640 |
356,882 |
4 |
Mar 08, 04:32 PM |
| Miller Joan Elizabeth |
SVP-Pathology & Hosp. Services |
Mar 04 |
Option Exercise |
$56.51 |
2,742 |
154,937 |
96,582 |
4 |
Mar 08, 04:31 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Mar 04 |
Option Exercise |
$56.51 |
748 |
42,266 |
16,457 |
4 |
Mar 08, 04:29 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Mar 01 |
Option Exercise |
$43.49 |
4,150 |
180,479 |
146,752 |
4 |
Mar 03, 04:12 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Mar 01 |
Sale |
$56.77 |
4,150 |
235,582 |
144,252 |
4 |
Mar 03, 04:12 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Mar 01 |
Option Exercise |
$48.74 |
20,555 |
1,001,851 |
388,527 |
4 |
Mar 03, 04:09 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Mar 01 |
Sale |
$56.75 |
20,555 |
1,166,535 |
367,972 |
4 |
Mar 03, 04:09 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Feb 18 |
Sale |
$57.46 |
8,685 |
499,045 |
45,888 |
4 |
Feb 22, 05:02 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Feb 15 |
Option Exercise |
$56.82 |
31,272 |
1,776,875 |
322,153 |
4 |
Feb 17, 06:18 PM |
| Simmons Wayne R. |
Vice President, Operations |
Feb 15 |
Option Exercise |
$56.82 |
4,851 |
275,634 |
49,846 |
4 |
Feb 17, 06:04 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Feb 15 |
Option Exercise |
$56.82 |
1,654 |
93,980 |
14,081 |
4 |
Feb 17, 06:03 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Feb 15 |
Option Exercise |
$56.82 |
13,002 |
738,774 |
125,354 |
4 |
Feb 17, 06:03 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Feb 15 |
Sale |
$57.17 |
1,540 |
88,042 |
36,694 |
4 |
Feb 16, 04:28 PM |
| PREVOZNIK MICHAEL E |
SVP & General Counsel |
Feb 11 |
Sale |
$57.19 |
18,457 |
1,055,556 |
38,153 |
4 |
Feb 16, 04:28 PM |
| Simmons Wayne R. |
Vice President, Operations |
Feb 11 |
Option Exercise |
$57.15 |
880 |
50,292 |
41,354 |
4 |
Feb 14, 07:45 PM |
| Simmons Wayne R. |
Vice President, Operations |
Feb 10 |
Option Exercise |
$57.28 |
918 |
52,583 |
41,664 |
4 |
Feb 14, 07:45 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Feb 10 |
Option Exercise |
$57.28 |
293 |
16,783 |
11,480 |
4 |
Feb 14, 07:44 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Feb 11 |
Option Exercise |
$57.15 |
294 |
16,802 |
11,186 |
4 |
Feb 14, 07:44 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Feb 09 |
Option Exercise |
$35.53 |
152,000 |
5,400,940 |
449,046 |
4 |
Feb 10, 05:07 PM |
| MOHAPATRA SURYA N |
Chairman, President & CEO |
Feb 09 |
Sale |
$57.53 |
152,000 |
8,745,122 |
297,046 |
4 |
Feb 10, 05:07 PM |
| BALDWIN JOHN C MD |
Director |
Feb 09 |
Option Exercise |
$44.76 |
30,000 |
1,342,900 |
40,002 |
4 |
Feb 10, 05:06 PM |
| BALDWIN JOHN C MD |
Director |
Feb 09 |
Sale |
$57.56 |
30,000 |
1,726,881 |
10,002 |
4 |
Feb 10, 05:06 PM |
| ZIEGLER JOHN B |
Director |
Feb 08 |
Option Exercise |
$46.87 |
21,180 |
992,730 |
37,884 |
4 |
Feb 09, 04:36 PM |
| ZIEGLER JOHN B |
Director |
Feb 08 |
Sale |
$58.57 |
21,180 |
1,240,426 |
16,704 |
4 |
Feb 09, 04:36 PM |
| WILENSKY GAIL R |
Director |
Feb 07 |
Option Exercise |
$29.53 |
20,000 |
590,524 |
35,226 |
4 |
Feb 09, 04:35 PM |
| WILENSKY GAIL R |
Director |
Feb 07 |
Sale |
$58.57 |
20,000 |
1,171,381 |
25,226 |
4 |
Feb 09, 04:35 PM |
| STANZIONE DANIEL |
Director |
Feb 07 |
Option Exercise |
$29.53 |
20,000 |
590,524 |
36,226 |
4 |
Feb 09, 04:33 PM |
| STANZIONE DANIEL |
Director |
Feb 07 |
Sale |
$58.92 |
20,000 |
1,178,322 |
31,226 |
4 |
Feb 09, 04:33 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Feb 07 |
Option Exercise |
$40.63 |
99,287 |
4,034,384 |
214,165 |
4 |
Feb 09, 04:32 PM |
| HAGEMANN ROBERT |
SVP & Chief Financial Officer |
Feb 07 |
Sale |
$58.92 |
99,287 |
5,849,504 |
114,916 |
4 |
Feb 09, 04:32 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Feb 07 |
Option Exercise |
$30.54 |
23,694 |
723,624 |
40,054 |
4 |
Feb 09, 04:30 PM |
| BONGIORNO THOMAS F |
VP and Corporate Controller |
Feb 07 |
Sale |
$58.75 |
28,729 |
1,687,757 |
16,360 |
4 |
Feb 09, 04:30 PM |
| GLAXOSMITHKLINE PLC |
Director |
Jan 31 |
Sale |
$54.96 |
30,755,151 |
1,690,226,257 |
15,377,551 |
4 |
Feb 02, 01:55 PM |
